Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02769676 · ClinicalTrials.gov registry record · NA

A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation

A NA study of Contraception, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT02769676: Completed NA study of Contraception, sponsored by Washington University School of Medicine.

NCT02769676 is a NA study of Contraception that has completed, run by Washington University School of Medicine. The registered enrollment target is 200 participants, below the 452-participant average among 72 other Contraception trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02769676, a NA study of Contraception, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The current postpartum care model of a single visit 4-6 weeks after delivery does not optimally address contraceptive needs. By this visit, many women have resumed sexual activity, potentially putting them at risk for unintended and rapid repeat pregnancy. In addition, many women with pregnancy-related Medicaid lose insurance coverage at this time, making it difficult to obtain long-acting reversible contraception (LARC) if desired. Therefore, an earlier postpartum visit may remove barriers to improve access to LARC thereby, reducing unintended and rapid repeat pregnancy. Our primary objective is to determine whether an additional 3-week postpartum visit, compared to usual postpartum care, will affect the initiation of LARC by 6 weeks postpartum.

Primary Outcome

Initiation of LARC method

Conditions Studied

Interventions

  • OTHER usual care
  • OTHER 3-week visit

Study Locations (1)

Missouri

  • Washington University in St Louis - St Louis

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2016-05
Est. Completion 2018-05
Phase NA

What the finished NCT02769676 record still lists

NCT02769676 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 452-participant average among 72 other Contraception trials with a reported enrollment target (56% lower).

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 2 interventions - of which usual care is the first listed.

NCT02769676 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT02769676 about?

NCT02769676 is a clinical study titled "A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation". The current postpartum care model of a single visit 4-6 weeks after delivery does not optimally address contraceptive needs. By this visit, many women have resumed sexual activity, potentially putting them at risk for unintended and rapid repeat pregnancy. In addition, many women with pregnancy-rela...

What is the current status of trial NCT02769676?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2016-05. Estimated completion is 2018-05.

What conditions does trial NCT02769676 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT02769676?

The interventions under investigation include: usual care (OTHER), 3-week visit (OTHER).

Who is sponsoring clinical trial NCT02769676?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02769676 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02769676's enrollment target sits among peer trials

200 34th of 72 higher than 38 of 72 other Contraception trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02769676, the US trial registry maintained by the National Library of Medicine. NCT02769676 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.